{"id":"W4388047647","doi":"10.1007/s00415-023-11943-4","title":"Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension","year":2023,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Universität Basel; F. Hoffmann-La Roche","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Placebo; Adverse effect; Internal medicine; Neurology; Randomized controlled trial; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02543611,0.001204435,0.002344132,0.0005254305,0.0003573901,0.001290738,0.0007272973,0.001610219,0.002143342],"category_scores_gemma":[0.0158569,0.0006394412,0.003499884,0.000573703,0.0008343148,0.001304197,0.0009206565,0.003117175,0.0003088694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000691976,"about_ca_system_score_gemma":0.001167789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003658783,"about_ca_topic_score_gemma":0.0006191871,"domain_scores_codex":[0.9884055,0.008909376,0.0004906921,0.0008593226,0.000761906,0.0005732268],"domain_scores_gemma":[0.987534,0.005584494,0.003138126,0.001576998,0.0007638836,0.001402455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9581308,0.003647894,0.01220446,0.0003825234,0.004862426,0.00007359573,0.00007531148,0.0006859484,0.001908063,0.0001793179,0.000830291,0.01701947],"study_design_scores_gemma":[0.689018,0.1964044,0.09162933,0.0001735316,0.009788343,0.0003068729,0.00008579611,0.004884555,0.002164003,0.000745683,0.004704686,0.00009489195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861671,0.00669091,0.001967737,0.0004403068,0.0002511778,0.001930034,0.001402176,0.00008929061,0.001061246],"genre_scores_gemma":[0.9914194,0.001072326,0.001669479,0.0005198704,0.0002026014,0.002162926,0.001990302,0.00002936096,0.0009338349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02543611,"threshold_uncertainty_score":0.1345206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1691772000045825,"score_gpt":0.4105459403302391,"score_spread":0.2413687403256565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}